Gene · 57650
Papers1,316
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,316
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDIAS shields vulnerable single-stranded DNA to direct neurogenesis and protect cancer cells. | Mol Cell | 2026 | 42822412 | PubTator, text mining | PubMed |
| Targeting Polθ Helicase with RP-3467: Preclinical Validation and Clinical Response in a gBRCA1 ovarian cancer patient with an acquired PARPi resistance mutation in TP53BP1. | medRxiv | 2026 | 42818163 | PubTator, text mining | PubMed |
| Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC. | Mol Cancer Ther | 2026 | 42704219 | PubTator, text mining | PubMed |
| Dynamic chromatin tethering of MDC1 regulates genome stability. | Nucleic Acids Res | 2026 | 42703974 | PubTator, text mining | PubMed |
| MAD2B guides chromosome stability in mitosis via the MAD2B-CIP2A signaling axis. | J Mol Cell Biol | 2026 | 42667364 | PubTator, text mining | PubMed |
| DDIAS shields single-stranded DNA in mitosis and promotes vertebrate brain development. | Cell | 2026 | 42636811 | PubTator, text mining | PubMed |
| Mitotic single-stranded DNA suppression by DDIAS. | Mol Cell | 2026 | 42636809 | PubTator, text mining | PubMed |
| Development of a structurally distinct TopBP1 inhibitor that enhances PARP blockade and reverses osimertinib resistance. | Sci Adv | 2026 | 42555732 | PubTator, text mining | PubMed |
| CIP2A-TOPBP1 complex and PP2A dynamically regulate Polθ recruitment and phosphorylation at mitotic DNA double-strand breaks. | Proc Natl Acad Sci U S A | 2026 | 42546199 | PubTator, text mining | PubMed |
| PP2A: Decoding Its Structure, Regulation and Therapeutic Applications in Neurological Disorders. | Curr Neuropharmacol | 2026 | 42522313 | PubTator, text mining | PubMed |
| ANLN: A New Hub in Glutamine Metabolism of Lung Adenocarcinoma by scRNA-Seq and Machine Learning. | Oncol Res | 2026 | 42500572 | PubTator, text mining | PubMed |
| Biosensors for oral cancer detection: a scoping review. | Diagn Pathol | 2026 | 42332789 | PubTator, text mining | PubMed |
| ARL13B is regulated by the ERK/P90 pathway and mediates TMZ resistance in glioblastoma via microvesicles. | Sci Rep | 2026 | 42324288 | PubTator, text mining | PubMed |
| CIP2A recruits SLX4-MUS81-XPF in mitosis and protects against replication stress. | EMBO Rep | 2026 | 42192029 | PubTator, text mining | PubMed |
| Determining optimal conformity index values in pelvic region radiotherapy planning under ICRU 50/62, ICRU 83, and RTOG/NRG guidelines. | J Appl Clin Med Phys | 2026 | 42178514 | PubTator, text mining | PubMed |
| Biomimetic PD-1 macrophage nanoplatform for Cip2a silencing and immune activation in oral squamous cell carcinoma. | J Nanobiotechnology | 2026 | 42057038 | PubTator, text mining | PubMed |
| A Novel CIP2A and BCL-XL Clinical Diagnostic Toolkit to Predict Disease Progression and Treatment-Free Remission in Chronic Myeloid Leukaemia. | Int J Mol Sci | 2026 | 41977180 | PubTator, text mining | PubMed |
Plasma proteomics implicates NOX-driven redox imbalance in degenerative cervical myelopathy: findings from the Australian MYelopathy Natural History Registry [AO Spine RECODE-DCM research priority number 5]. | Redox Rep | 2026 | 41902769 | PubTator, text mining | PubMed |
| Resveratrol Mimics Exercise-Induced Metabolic Stress to Suppress CIP2A and Epithelial-Mesenchymal Transition in 3D Renal Carcinoma Spheroids. | Biomedicines | 2026 | 41898246 | PubTator, text mining | PubMed |
| Glycemic variability and reference percentiles in very low birth weight preterm infants using continuous glucose monitoring. | PLoS One | 2026 | 41894434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57650/papers